top of page
About us
A Noval Penetration Enhancer
CoR-Tech has, for the first time in nearly 200 years since the discovery of mitochondria, demonstrated the ability to directly penetrate double membranes to reach mitochondria, enhancing ATP and FAD production. This innovation marks a significant milestone in intracellular and organelle communication.
US Patent No: 11273135 and more
HOW IT WORKS
CoR-Tech utilizes an innovative polar solvent with unique negative charge properties. This non-toxic, nature-derived molecule serves as both a delivery carrier and therapeutic agent, enhancing safety and efficacy while simplifying current drug delivery methods compared to traditional nanomaterials and engineered viral techniques.
OUR MISSION & VISION
Paving the way for a world where sickness is optional
We execute the segmental transfer of CoR IP rights through interested buyers, partnerships, or licensing.
bottom of page